Differences in Reporting Pearl Indices in the United States and Europe: Focus on a 91-Day Extended-Regimen Combined Oral Contraceptive With Low-Dose Ethinyl Estradiol Supplementation

European Journal of Contraception and Reproductive Health Care - United Kingdom
doi 10.3109/13625187.2015.1059416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Efficacy in Suppressing Ovulation and Safety of a Low Dose Oral Contraceptive in a Continuous Regimen (84+7) With Continuous Ethinyl Estradiol Instead of a Hormone-Free Interval: An Evaluation of Ovulation Suppression and Ovarian Activity

World Journal of Gynecology & Womens Health
2020English

Unscheduled Bleeding in Combined Oral Contraceptive Users: Focus on Extended-Cycle and Continuous-Use Regimens

Journal of Family Planning and Reproductive Health Care
2009English

A Combined Oral Contraceptive Containing 30 MCG Ethinyl Estradiol and 3.0 Mg Drospirenone Does Not Impair Endothelium-Dependent Vasodilation

Contraception
GynecologyReproductive MedicineObstetrics
2010English

Drospirenone/Ethinyl Estradiol 3 Mg/20 &Micro;g (24/4 Day Regimen): Hormonal Contraceptive Choices &Ndash; Use of a Fourth-Generation Progestin

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2009English

Yasminelle®: A New Low-Dose Combined Oral Contraceptive Containing Drospirenone

Women's Health
Medicine
2006English

The Evra (Ethinyl Estradiol/Norelgestromin) Contraceptive Patch: Estrogen Exposure Concerns

CMAJ
Medicine
2006English

Endometrial Safety With a 1-Year Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System [5M]

Obstetrics and Gynecology
GynecologyObstetrics
2019English

An Overview of the Development of Combined Oral Contraceptives Containing Estradiol: Focus on Estradiol Valerate/Dienogest

Gynecological Endocrinology
GynecologyEndocrinologyMetabolismObstetricsDiabetes
2012English

Efficacy and Tolerability of a Monophasic Combined Oral Contraceptive Containing Nomegestrol Acetate and 17β-Oestradiol in a 24/4 Regimen, in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Drospirenone in a 21/7 Regimen

European Journal of Contraception and Reproductive Health Care
MedicineGynecologyReproductive MedicinePharmacologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy